Bumper Offer - Urjas oil Just @ Rs. 1
Diclonac MR Tablet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Muscle Pain, Toothache, Rheumatic Pain. Diclonac MR Tablet also has some secondary and off-label uses. These are listed below.
The right dosage of Diclonac MR Tablet depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Diclonac MR Tablet can also lead to other problems, which have been listed below. These side effects of Diclonac MR Tablet are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Diclonac MR Tablet is Severe for pregnant women and Mild for women who are breastfeeding. Further, the section on Diclonac MR Tablet related warnings talks about Diclonac MR Tablet's effects on the liver, heart and kidney.
Diclonac MR Tablet is contraindicated in people with pre-existing medical conditions like Stomach Infection, Skin Rash, Stroke as it can result in adverse effects. Other conditions have been mentioned below in the Diclonac MR Tablet contraindications section.
Drug interactions for Diclonac MR Tablet have been reported in the medical literature. See below for a complete list.
You should also be aware that Diclonac MR Tablet is safe while driving, and is addiction.
Diclonac MR Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Diclonac MR Tablet is used -
Severe
Moderate
Mild
Is the use of Diclonac MR Tablet safe for pregnant women?
Diclonac should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Diclonac MR Tablet safe during breastfeeding?
Side effects of Diclonac on breastfeeding women are very mild.
What is the effect of Diclonac MR Tablet on the Kidneys?
Use of Diclonac may be dangerous for kidney. Do not use it without doctor advice.
What is the effect of Diclonac MR Tablet on the Liver?
Diclonac can cause side effects that could harm the liver. So medical advice before taking it is necessary.
What is the effect of Diclonac MR Tablet on the Heart?
Diclonac may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
Diclonac MR Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Diclonac MR Tablet unless your doctor advises you to do so -
Is this Diclonac MR Tablet habit forming or addictive?
Diclonac MR Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Diclonac MR Tablet will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but take Diclonac MR Tablet only as per medical advice.
Is it able to treat mental disorders?
Diclonac MR Tablet is unable to treat or cure mental disorders.
Interaction between Food and Diclonac MR Tablet
Due to the absence of research, it is difficult to say how Diclonac MR Tablet and food will interact.
Interaction between Alcohol and Diclonac MR Tablet
Consuming Diclonac MR Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
